How much does Breo Ellipta cost in the US compared with other countries?
US pharmacies paid about $390 for one 30-dose Breo Ellipta inhaler in November 2026, and about $229 for the authorized generic (CMS NADAC). Medicare’s negotiated price from January 1, 2027 is $67 for a 30-day supply (CMS). In Europe the same inhaler is sold as Relvar Ellipta: £22.00 in the UK, €28.38 in France, €29.94 in the Netherlands, €40.85 in Austria (excl. VAT) and CHF 44.70 in Switzerland; Germany’s price ceiling is €34.46 — about $30 to $55 at ECB rates.
